Drugs Made In America Acquisition II Corp.
NASDAQ: DMIIR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
- CEO
- Roger Bendelac
- Headquarters
- Fort Lauderdale, United States
- IPO year
- 2025
- Market cap
- $5.6M
- Website
- https://dmaacorp.com/
Loading DMIIR…
Loading profile data…Frequently asked questions about DMIIR
What does Drugs Made In America Acquisition II Corp. (DMIIR) do?
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered i...
Where does DMIIR trade?
Drugs Made In America Acquisition II Corp. (DMIIR) trades on the NASDAQ.
What sector is DMIIR in?
Drugs Made In America Acquisition II Corp. (DMIIR) operates in the Financial Services sector, specifically in the Financial - Conglomerates industry.
Who is the CEO of Drugs Made In America Acquisition II Corp.?
Roger Bendelac is the chief executive officer of Drugs Made In America Acquisition II Corp. (DMIIR).
Where is Drugs Made In America Acquisition II Corp. headquartered?
Drugs Made In America Acquisition II Corp. is headquartered in United States.
Does DMIIR pay a dividend?
Drugs Made In America Acquisition II Corp. (DMIIR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DMIIR go public?
Drugs Made In America Acquisition II Corp. (DMIIR) completed its initial public offering in 2025.